These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1346992)

  • 1. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
    Kuo BS; Kusmik WF; Poole JC; Elsea SH; Chang J; Hwang KK
    Drug Metab Dispos; 1992; 20(1):23-30. PubMed ID: 1346992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbation of epidermal growth factor clearance after radioiodination and its implications.
    Kuo BS; Nordblom GD; Wright DS
    J Pharm Sci; 1997 Mar; 86(3):290-6. PubMed ID: 9050795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition kinetics of human epidermal growth factor (hEGF1-53) and its truncated fragment (hEGF1-48) in rats.
    Kuo BS; Nordblom GD; Dudeck RC; Kirkish LS; Wright DS
    Drug Metab Dispos; 1996 Jan; 24(1):96-104. PubMed ID: 8825196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies.
    Widness JA; Schmidt RL; Veng-Pedersen P; Modi NB; Sawyer ST
    J Lab Clin Med; 1992 Mar; 119(3):285-94. PubMed ID: 1311741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach.
    Arany E; Zabel P; Hill DJ
    Growth Regul; 1996 Mar; 6(1):32-41. PubMed ID: 8717448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys.
    Nadeau RW; Satoh H; Scheide S; Crowl R; Conroy R; Garland WA; Liberato DJ
    Drug Metab Dispos; 1995 Sep; 23(9):904-9. PubMed ID: 8565779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered pharmacokinetics of recombinant human deoxyribonuclease in rats due to the presence of a binding protein.
    Mohler M; Cook J; Lewis D; Moore J; Sinicropi D; Championsmith A; Ferraiolo B; Mordenti J
    Drug Metab Dispos; 1993; 21(1):71-5. PubMed ID: 8095230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the pharmacokinetics of small proteins by iodination.
    Bauer RJ; Leigh SD; Birr CA; Bernhard SL; Fang M; Der K; Ihejeto NO; Carroll SF; Kung AH
    Biopharm Drug Dispos; 1996 Dec; 17(9):761-74. PubMed ID: 8968529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue disposition and pharmacokinetics of recombinant human nerve growth factor after acute and chronic subcutaneous administration in monkeys.
    Nguyen CB; Harris L; Szönyi E; Baughman SA; Hale VG; Dybdal NO; Sadick MD; Escandón E
    Drug Metab Dispos; 2000 May; 28(5):598-607. PubMed ID: 10772641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and interspecies scaling of recombinant human factor VIII.
    Mordenti J; Osaka G; Garcia K; Thomsen K; Licko V; Meng G
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):75-8. PubMed ID: 8560482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable?
    Ducongé J; Fernández-Sánchez E; Alvarez D
    Biopharm Drug Dispos; 2004 May; 25(4):177-86. PubMed ID: 15108220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. First communication: plasma concentration, distribution, metabolism and excretion of the new monoclonal antibody, regavirumab after intravenous administration in rats and rabbits.
    Arizono H; Ishii S; Nagao T; Kudo S; Sasaki S; Kondo S; Kiyoki M
    Arzneimittelforschung; 1994 Jul; 44(7):890-8. PubMed ID: 7945529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution and plasma clearance of heparin-binding EGF-like growth factor (HB-EGF) in adult and newborn rats.
    Feng J; Mehta VB; El-Assal ON; Wu D; Besner GE
    Peptides; 2006 Jun; 27(6):1589-96. PubMed ID: 16364500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of recombinant factor VIIa in the rat--a comparison of bio-, immuno- and isotope assays.
    Thomsen MK; Diness V; Nilsson P; Rasmussen SN; Taylor T; Hedner U
    Thromb Haemost; 1993 Sep; 70(3):458-64. PubMed ID: 8259549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.
    Lin YS; Nguyen C; Mendoza JL; Escandon E; Fei D; Meng YG; Modi NB
    J Pharmacol Exp Ther; 1999 Jan; 288(1):371-8. PubMed ID: 9862791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of recombinant tissue factor pathway inhibitor (TFPI) in rabbits.
    Palmier MO; Hall LJ; Reisch CM; Baldwin MK; Wilson AG; Wun TC
    Thromb Haemost; 1992 Jul; 68(1):33-6. PubMed ID: 1514170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats.
    Appasamy R; Tanabe M; Murase N; Zarnegar R; Venkataramanan R; Van Thiel DH; Michalopoulos GK
    Lab Invest; 1993 Mar; 68(3):270-6. PubMed ID: 8450646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nephrectomy on the pharmacokinetics of various cloned human interferons in the rat.
    Tokazewski-Chen SA; Marafino BJ; Stebbing N
    J Pharmacol Exp Ther; 1983 Oct; 227(1):9-15. PubMed ID: 6620174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.